疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

/ x+ l# V$ w! Q% V$ P

Vaccines, 6th Edition

( T# p3 S: d1 ~5 [& ~/ NApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
) U+ h0 S: f( I4 t- }
6 d0 |; w0 `+ w3 u$ q* {7 I8 {5 Dhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
, k& n# }3 ?" Q# N4 h4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
3 t" |# w# M8 H* _4 |: f% R8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
" i; u3 C& N7 }8 L10 Anthrax vaccines 127
7 N0 g& z) Y* I2 `9 R4 A4 [& V11 Cholera vaccines 141
4 y+ i# S+ E6 U4 r# [0 Y3 y12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
* ]$ ^  Q, s: _6 Q7 m4 t19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
! g4 \9 d, p" \* H% ?( V. F$ f23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
- `9 A. F5 @8 q6 N$ h28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
, W! N, s9 m" e9 N# J34 Tick-borne encephalitis virus vaccines 773
) K; K* h% [4 w" P2 x8 G. |4 v35 Tuberculosis vaccines 789
5 R) [4 {5 z8 f. T% {36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
& F8 N% T% w7 H1 b4 v& J' r1 \39 Zoster vaccine 969
4 `, {: t, g* j& }# n( s, {40 Combination vaccines 981
  N2 O* e# a" E' I: WSECTION 3: Vaccines in development and new vaccine strategies
& }" y) @. v1 T2 h1 Z41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
2 M: \7 i* `/ n6 ^6 R- P+ j6 d9 j# b43 Cytomegalovirus vaccines 1032
. i% W( ?/ M; m) e+ ]44 Dengue vaccines 1042
8 T$ m& ~- V0 }- r% f45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
. V& r9 |0 |( H  D* k3 G47 Epstein-Barr virus vaccines 1068
$ S0 j, Q4 s6 n3 P. z8 b48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
5 T) f" ^( o5 A& A, c9 y51 Human immunodeficiency virus vaccines 1097
# B+ |4 T# f6 l52 Lyme disease vaccines 1122
- G3 H- T' D: n1 T/ f" J; S53 Malaria vaccines 1133
3 N6 L8 `& ~* f54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
  p2 s' o* l. N+ k5 D+ }0 k' n6 Q' n56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
7 j: o( X6 B  @* N58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
+ ]) @3 n/ r; C# m. q. q. x) q61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
" E1 F: l6 ]0 y65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
; E; ^% f+ l& U, Z; cSECTION 5: Public health and regulatory issues
+ t, `7 m4 G' @: J% d67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
# g9 g' M  o/ k: P; }& h75 Regulation of vaccines in developing countries 1454
  n5 S; g, s1 _! C8 j$ ]0 O3 s76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508



, H! W$ {! W$ Q5 U+ Z. E6 z6 Y$ G
$ _5 H: X$ S3 l0 [1 w$ _

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
- k, r8 c% B! Y3 t# H  Z7 F
1 M3 I: ~& }6 g" @0 C: `Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
: C, `$ ]4 K* U
( I% a- v. Q1 ^' e9 _6 l1 q* Phttp://yun.baidu.com/share/link? ... 1&uk=3810996606
, T& u- ]" p* D2 P5 Y
6 @4 ], Q# |, F+ J! A+ B0 y: i0 @SECTION 1: General aspects of vaccination
. D- D. a) o" }+ V% r% w# h1 A short history of vaccination 1
& L0 t0 R  o7 E2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
' r4 {$ w, [; o1 G5 t% O% c5 Evolution of adjuvants across the centuries 58
, b. g) ?  |( @7 U+ O6 Vaccine additives and manufacturing residuals in the United States:
$ v. Q! s0 {# |5 Ulicensed vaccines 71
7 Passive immunization 80
' x: {9 r- S8 M1 R) h! k. w8 General immunization practices 88
' v0 p% I5 o6 Y, S5 V: S% F$ `* `SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
" v% i: ?1 N( V- u4 u. e11 Cholera vaccines 141
/ T0 g) N1 A1 k! C12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
- Y6 M/ h! i, ~) A4 }15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
: `" x" P% ?5 H& s17 Inactivated influenza vaccines 257
0 W5 ^& _" v7 V, Q. `9 _18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
6 H, x0 K+ M# B20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
8 i* n0 w  U6 n" C+ a23 Pertussis vaccines . 447
$ ]/ M$ A1 m! S) Z9 N. p24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
/ k6 m) x* \! ^# F27 Poliovirus vaccine-inactivated . 573
2 V9 U: `& k! q$ d& h" J8 g4 ?  w28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
# F* U" E9 ~3 c, ]30 Rotavirus vaccines . 669
31 Rubella vaccine 688
* i4 k. A2 x  P9 k8 @% [" Q/ X32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
( h9 R5 g0 c' T5 V! i34 Tick-borne encephalitis virus vaccines 773
5 V& C, g' n) p$ Y& W% Q35 Tuberculosis vaccines 789
) x) g$ y: r# q36 Typhoid fever vaccines 812
- U) ]3 c* S. Y; h37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
2 N# L: f) {6 ?+ k40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
. V: G3 A( j" o, X45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
: p" a  l$ g4 T  D47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
! T# I) i! Q9 [. A' m' w49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
8 @+ D, T- w+ x54 Noninfectious disease vaccines 1138
( O, w% ~5 Y  ?& [! m55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
5 h$ n0 W) ~' e% x/ H) s" N57 Staphylococcus aureus vaccines 1161
, A0 U. h+ {6 D  N# t58 Streptococcus group A vaccines 1169
" ]" k" Z/ R# r' x7 \' _! v59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
; Z. _5 p7 C# d: f64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
1 t0 a  l  Z8 r- H! f# `66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
, s1 I0 D8 \* Z6 Y9 P0 G+ M67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
4 Q& @1 _3 P7 J3 Y70 Immunization in developing countries 1369
71 Community immunity 1395
7 o5 b! T! U$ `; h5 R, U# }; S- T. x72 Economic analyses of vaccine policies 1413
. ^0 M3 X8 @4 _, i73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
6 p# K5 u0 ~. R' T" M& S3 i75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
' d- m) b4 P- w% F) s7 _- f( W" Z' \2 e78 Ethics 1508

casarett

Vaccines, 6e, 2012

3 A  j9 V7 h6 U3 v3 t- RHardcover: 1570 pages
8 |' Q2 B1 c  F' n" [" mPublisher: Saunders; 6 edition (October 30, 2012)
) ~5 ~& Y# t& E: O4 V" X+ eLanguage: English
2 J1 M" G, p- Q) }ISBN-10: 1455700908
Size: 52.3mb (original pdf)

4 q8 w* V, G1 N+ ^3 v# P( O2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
0 b+ i0 U4 i8 b% @( P
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
6 N8 f/ q6 H' ?- X) rPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
& V$ L. M" ?0 a/ v0 _% @' C- n3 fMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
9 m" H$ \1 k+ J3 l9 C
! n2 w; n: W6 iDownload link: http://pan.baidu.com/s/1i5NxwLR
/ l5 t  _3 a7 K/ bCode for downloading: dv96
+ ?$ \, b; T& p! v: ^1 a2 J5 K